AIG
PSTX

American International Group’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

American International Group’s Portfolio PSTX Stock Details PSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-33,494
Closed -$107K – 2907
2024
Q1 		$107K Sell
33,494
-288
-0.9% -$960 ﹤0.01% 2479
2023
Q4 		$114K Sell
33,782
-136
-0.4% -$350 ﹤0.01% 2487
2023
Q3 		$80.7K Buy
33,918
+1,206
+4% +$2.53K ﹤0.01% 2629
2023
Q2 		$57.6K Buy
+32,712
New +$83.6K ﹤0.01% 2844
2022
Q2 		– Sell
-14,279
Closed -$64K – 3304
2022
Q1 		$64K Sell
14,279
-1,006
-7% -$4.54K ﹤0.01% 2755
2021
Q4 		$104K Sell
15,285
-456
-3% -$3.11K ﹤0.01% 2698
2021
Q3 		$115K Sell
15,741
-375
-2% -$3.22K ﹤0.01% 2745
2021
Q2 		$161 Sell
16,116
-3,181
-16% -$28.5K ﹤0.01% 2646
2021
Q1 		$184 Buy
19,297
+11,492
+147% +$113K ﹤0.01% 2412
2020
Q4 		$86 Sell
7,805
-225
-3% -$2.37K ﹤0.01% 2738
2020
Q3 		$71K Buy
+8,030
New +$91.4K ﹤0.01% 2718

Other funds holding PSTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

American International Group's PSTX Position: Q2 2024 in Review

American International Group sold out of Poseida Therapeutics, Inc. Common Stock (PSTX) in Q2 2024, closing a stake of 33,494 shares — an estimated $107K sold.

American International Group first reported a position in PSTX in Q3 2020 and held it in 11 quarters. The position peaked at $115K in Q3 2021. 93 funds tracked by Wall St. Rank hold PSTX as of Q2 2024.

  • American International Group reported no remaining Poseida Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 33,494 Poseida Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $107K.
  • American International Group first reported a position in Poseida Therapeutics, Inc. Common Stock in Q3 2020 and held it in 11 quarters.
  • American International Group's Poseida Therapeutics, Inc. Common Stock position peaked at $115K in Q3 2021.
  • 93 funds tracked by Wall St. Rank held Poseida Therapeutics, Inc. Common Stock as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.